hdxsim: a clinical decision support tool for model-informed precision dosing of hydroxyurea in scd
Published 4 months ago • 34 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
1:43
approval of exa-cel for scd
-
1:36
the limitations and future of precision medicine in sickle cell disease
-
1:11
precision medicine in sickle cell disease: current status and future outlooks
-
1:25
recent fda approval of exa-cel & lovo-cel for patients with scd
-
5:57
reach: hydroxyurea for sickle cell anemia in sub-saharan africa
-
1:25
the use of clonoseq to monitor mrd in patients with lbcl treated with axi-cel in zuma-7
-
21:07
chemotech clinical update - july 2024
-
28:44
acute normovolemic hemodilution primer
-
21:07
cellsaverelite
-
0:45
difference between quality of life & patient-reported outcomes
-
1:45
ham-ven as salvage treatment for r/r aml: results from the sal-relax trial
-
1:20
axi-cel in r/r fl: an updated comparison of zuma-5 and the scholar-5 external control cohort
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
3:25
identifying & monitoring patients with high-risk clonal hematopoiesis
-
1:59
real-world outcomes of ide-cel in heavily pre-treated r/r mm
-
2:05
cell salvage and hemodilution
-
0:36
the use of ai for analyzing genetic and molecular data in cll
-
2:13
haploidentical sct for the treatment of secondary aml
-
4:45
safety and efficacy of obe-cel in r/r adult b-all: results of the pivotal felix study
-
1:09
improving the mental health and psychological resilience of patients with scd
-
2:19
hydroxyurea use in sickle cell and other conditions